A Food and Drug Administration (FDA) advisory panel on June 15 voted to recommend the FDA give emergency authorization to the Moderna and Pfizer COVID-19 vaccines for children as young as 6 months of age.
The panel unanimously voted during a virtual meeting after presentations from the companies and the FDA.
The FDA has yet to choose whether to accept the recommendations, but it is expected to do so. An agency spokeswoman told The Epoch Times via email she could shed no light in terms of timing.
No COVID-19 vaccines are currently available to children under five in the United States.
Panel members heard that a two-dose primary series of Moderna’s vaccine was just 50.6 percent effective against symptomatic infection in children aged 6 months to 23 months, and just 36.8 percent for children aged 2 to 5….